Paddock Capital Inc. is an investment firm founded and based in Calgary, Alberta. Its philosophy explores an Albertan future beyond combustion, where technology, sustainable economic growth, environmental stewardship, human physical and mental vitality, and educational opportunity are not a series of trade-offs, but necessary partners.

Paddock Capital

Aphelion Capital is a venture capital firm focused on supporting the growth of innovative medical technology with an emphasis on fast to market, low capital intense products that reduce the cost of delivering quality healthcare.   They leverage their considerable knowledge and deep networks to accelerate commercial success of a company. Their team has extensive experience investing in healthcare companies across both the private and public equity markets.

Aphelion Capital

Founded in 2008, Anges Québec is a network of more than 230 angel investors whose mission is to invest capital and time in innovative Québec-based companies from all sectors of activity. The members of the Anges Québec network have, to date, invested more than $ 80 million in the Québec economy, with more than 210 investments in more than 115 innovative companies. Thanks to its professional development center, Anges Québec supports its members in the constant acquisition of new knowledge and skills inherent in the investment.

Anges Quebec

Relentless Pursuit Partners is an early stage fund dedicated to investing in preventative and proactive technology solutions that optimize health, activity and longevity.

Relentless Pursuit Partners

InterGen Capital deploys capital into post-seed, pre-Series A companies led by extraordinary teams with proven solutions and big markets. The firm has a strong network of retired and transitioning executives looking to engage with innovative companies emerging from start-up to scale-up. InterGen Capital was founded in 2018 and is located in Calgary, Alberta.

InterGen Capital

ICM Asset Management fixates on managing and investing in real estate, private equity and private debt to engender investment returns.

ICM Asset Management

Thin Air Labs is the leading investment firm in Canada focused on the growth asset class in innovation and technology. We currently have 24 companies in our portfolio. We believe in igniting venture growth for greater human impact.

Thin Air Labs

Picante Capital

Viewpoint Group is a family office, involved in the responsible stewardship of capital, transformational philanthropic initiatives, and research and thought leadership in advanced practices. Originally created out of the need to support the Van Wielingen family and their capital, Viewpoint has evolved into two primary areas: Viewpoint Investment Partners and Viewpoint Foundation.

Viewpoint

Orpyx Medical Technologies

Orpyx Medical Technologies empowers people with diabetes to maintain mobility. The company’s core product line, the Orpyx SI sensory insoles with remote patient monitoring, helps manage and prevent diabetic foot ulcers and limb loss through advanced foot sensor technology and real-time analytics. Orpyx technology is also used by researchers to access clinical-grade plantar pressure data for health and human performance applications in the fields of sports medicine, therapeutic applications, and footwear design. Orpyx is focused on collaborating with stakeholders around the world to achieve a healthcare future that is prevention-focused and sustainable in cost.  Orpyx Medical Technologies was founded in 2010 and is headquartered in Calgary, Alberta, Canada.

Orpyx Medical Technologies is a digital health company that specializes in developing wearable sensor technology for diabetic foot ulcer (DFU) prevention and management. Orpyx's flagship product is the Orpyx SI Flex Sensory Insole system, a smart insole technology that helps prevent plantar foot complications in patients with peripheral neuropathy. The system uses advanced multi-modal sensors to continuously monitor critical parameters such as plantar pressure, temperature, activity, and adherence.

Calgary’s Orpyx raises $7.6 million Series A to commercialize, develop shoe-based diabetes tech

Orpyx® launches Orpyx SI® Flex Sensory Insoles and Diabetes Healthspan Extension care model

Orpyx launches Orpyx SI Flex Sensory Insoles and D

Orpyx Medical Technologies - Siksika Health Services

Membership-based, non-insurance healthcare companies helping maintain a steady state of well being.

Preventive Healthcare

Orpyx Medical Technologies is a digital health company founded in 2010 and based in Calgary. The company specializes in developing wearable sensor technologies for diabetic foot care and wound prevention. Their flagship product is the Orpyx SI Flex Sensory Insole system, which was launched in June 2022. This system consists of ultra-thin, prefabricated sensory insoles that fit into everyday footwear and are designed to prevent plantar foot complications in patients with peripheral neuropathy. The insoles contain embedded sensors that measure real-time physiological and physical parameters such as pressure, temperature, gait, activity, and movement symmetry.
The Orpyx SI Flex system works by capturing data on plantar pressure, wear time, step count, and temperature. This information is then uploaded to a cloud-based dashboard where healthcare practitioners can remotely monitor it. The system aims to prevent diabetic foot ulcers (DFUs) by detecting sustained high pressure and providing real-time feedback to patients through audiovisual alerts and offloading instructions sent to smartphones and smartwatches. In addition to the insoles, Orpyx offers Remote Patient Monitoring (RPM) services to support patient engagement through data analytics and coaching.
The company's technology has shown promising results. A 2019 study published in The Lancet Digital Health Journal demonstrated up to an 86% reduction in DFU recurrence with the use of smart insole technology compared to standard care. The Orpyx SI Sensory Insole system is registered with Health Canada and the US Food and Drug Administration.
Orpyx's approach focuses on prevention rather than treatment, aiming to address the significant healthcare burden of DFUs. According to the company, 25% of people with diabetes develop foot ulcers over their lifetime, with associated complications often leading to amputation. The company's technology is also utilized by researchers in sports medicine, therapeutic applications, and footwear design due to its ability to provide clinical-grade plantar pressure data.

Orpyx Medical Technologies is a digital health company that specializes in developing wearable sensor technology for diabetic foot ulcer (DFU) prevention and management. Orpyx's flagship product is the Orpyx SI Flex Sensory Insole system, a smart insole technology that helps prevent plantar foot complications in patients with peripheral neuropathy. The system uses advanced multi-modal sensors to continuously monitor critical parameters such as plantar pressure, temperature, activity, and adherence.The Orpyx SI Flex Sensory Insoles fit into everyday footwear and collect real-time data on foot health. This data is then uploaded to a cloud-based dashboard that healthcare practitioners can remotely monitor. The system also provides audiovisual alerts and offloading instructions to patients via smartphones and smartwatches when it detects a risk of foot injury. In clinical studies, Orpyx's technology demonstrated up to an 86% reduction in DFU recurrence compared to standard care.In June 2022, Orpyx launched its remote patient monitoring services to complement the sensory insole system. This program aimed to drive patient engagement and extend mobility for people with diabetes through real-world data analytics and coaching. The company's approach focuses on preventing foot ulceration by generating comprehensive plantar data, shifting away from the traditional focus on treating ulcers after they form.Key customers and partnershipsOrpyx partners with health plans and organizations like the Veterans Health Administration to prevent diabetic foot ulcers and amputations.&nbsp;In June 2019, Orpyx partnered with Onduo to expand market solutions for virtual type two diabetes care. The partnership allowed Onduo clients to access Orpyx foot ulcer sensors for their diabetes population, while Orpyx clients could access Onduo's Virtual Diabetes Clinic.

Cardiomo Care is developing noninvasive wearable devices to alert users and caretakers when there are abnormalities in the heartbeat. The company’s AI engine, trained on existing and growing data sets, can predict potential heart issues up to two hours before they occur, enabling early detection and intervention for arrhythmias and other cardiovascular diseases (CVDs).The company's product, CardiomoPatch, is a waterproof, wearable patch capable of long-term wear with a 10-day battery life. The patch monitors a patient's cardiac data, including ECG outputs, breathing, and skin temperature, and transmits the data via a mobile app for analysis by Cardiomo's AI engine.&nbsp;As of May 2024, the company is yet to commercialize its product and has over 1,600 pre-orders.

Cardiomo Care

Omada is a prevention-focused digital therapeutics startup that helps members achieve health goals through lifestyle changes. It offers four evidence-based, virtual prevention programs for managing hypertension, musculoskeletal (MSK) issues, prediabetes, and diabetes.Omada offers real-time data tracking through connected devices (such as wireless scales, blood pressure, and glucose monitors) and access to personalized coaching sessions via a mobile app as part of its prevention program. It also provides an online community of peers with similar health conditions to discuss challenges and provide support. In May 2021, Omada became the first fully-virtual healthcare provider to earn the National Committee for Quality Assurance’s Population Health Program Accreditation for its type 2 diabetes and type 2 diabetes + hypertension programs.Unlike its peers, Omada operates a performance-based business model where it charges clients an enrollment fee based on the number of users and a performance fee based on how much weight their employees lose. In May 2020, the company acquired virtual physical therapy startup Physera.Key customers and partnershipsAs of May 2024, Omada had more than 1 million members from more than 1,900 enterprise clients across all 50 US states. Its B2B employer and health plan client base include key clients such as American Eagle, Kaiser Permanente, Costco Wholesale, 3M, and Marvin. Additionally, the company has partnered with health systems and hospitals such as Intermountain Healthcare to provide its preventive programs as a covered benefit.In <a href="https://sp-edge.com/updates/15587">January 2023</a>, the company partnered with health service company Castell (a subsidiary of Intermountain Healthcare) to provide its diabetes programs to members from Intermountain Healthcare’s primary care providers in its Utah Medical Group. Further in <a href="https://sp-edge.com/updates/25245">January 2024</a>, the company partnered with Amazon to expand access to its cardiometabolic program.

Omada Health

VillageMD provides primary care services for patients. It also provides tools, technology, and staffing support needed for physicians to deliver high-quality services. VillageMD’s service delivery methods include traditional freestanding clinics, Village Medical at Walgreens co-located clinics, as well as at-home and around-the-clock virtual visits. It also leverages a team-based approach to care where physicians lead nurse practitioners, pharmacists, mental health specialists, and dietitians to offer a holistic care program. The technology of VillageMD includes docOS, an operating system that enables better patient care by connecting various clinical source systems with ongoing patient-generated data coupled with an AI engine to continuously analyze messages to enable patient self-care.The company made several acquisitions to expand its footprint: 1) <a href="https://sp-edge.com/updates/14347">Summit Health</a> for USD 8.9 billion in November 2022, 2) Healthy Interactions, an interactive patient education platform, in February 2022, and 3) <a href="https://sp-edge.com/updates/16968">Starling Physicians</a>, a primary care and specialty care provider, in March 2023.Key customers and partnershipsIn June 2020, VillageMD and Walgreens Boots Alliance announced a collaborative effort to open at least 600 Village Medical centers at Walgreens across more than 30 US markets by 2025. Walgreens invested USD 5.2 billion in VillageMD (from the previously announced USD 1.0 billion), raising its ownership stake to 63% (from 30%).However, as of May 2024, Walgreens had plans to close 160 VillageMD clinics as part of a cost-cutting plan.

VillageMD

Cityblock Health is a value-based healthcare provider focused on delivering comprehensive care to underserved communities, primarily Medicaid and lower-income Medicare beneficiaries. The company combines primary care, behavioral health, and social services to address the complex physical, mental, and social needs of its members.Cityblock's model involves partnering with local community-based organizations and deploying multidisciplinary care teams that include doctors, nurses, behavioral health specialists, and community health workers. These teams provide personalized care through 24/7 access to multi-modal care delivery, including in-home visits, telehealth, and community health hubs.The services of Cityblock are available to members at no additional cost if they are covered by an eligible health plan.Key Customers and PartnershipsAs of May 2024, the company’s services were available in seven states across the US and served over 100,000 members.In May 2024, it partnered with <a href="https://sp-edge.com/updates/29647">Sunshine Health</a> to expand to Florida, and, in <a href="https://sp-edge.com/updates/13270">September 2022</a>, it partnered with MDwise to expand into Indiana. Prior to that, the company had partnered with insurance providers such as ConnectiCare (Connecticut), Tufts Health Plan (Massachusetts), Emblem Health (New York), Healthy Blue (North Carolina), Molina Healthcare (Ohio) and CareFirst (Washington DC).Funding and FinancialsCityblock is a spin-off of Sidewalk Labs, an Alphabet company that incubates and invests in tech companies and products to improve urban infrastructure. It completed a USD 400 million Series D funding round led by Softbank in <a href="https://sp-edge.com/updates/5326">September 2021</a>, valuing the company at USD 5.7 billion. The funds were used to expand its services.

Cityblock Health

Everside Health (formerly Paladina Health) offers preventative care for chronic conditions and primary, mental and occupational healthcare treatments for acute conditions. Patients benefit from around-the-clock access to care, same-day or next-day appointments for in-person, and virtual care visits with zero copays.Everside aims to generate around 17% healthcare cost savings in three years and 31% in five years for its corporate members by leveraging a data-driven approach to care coordination.The company leverages data from past medical records, predictive analytics, and AI in the delivery of preventative care services.Founded in 2010 under the name Paladina Health, the company was rebranded in November 2020 as Everside Health following a merger between three primary care groups (Paladina, Activate Healthcare, and Healthstat). Furthermore, in February 2024, Everside Health merged with primary care provider Marathon Health to form a combined entity that would operate as Marathon Health, and, as of May 2024, the integration was ongoing.Key customers and partnershipPost-merger with Marathon Health, the combined entity would serve 2.5 million patients through over 680 clinics across 41 states.Funding and financialsThe company received its most recent investment in July 2022, amounting to USD 164 million in growth equity funding. The round was led by New Enterprise Associates (NEA). The funds were allocated toward growing its market presence and exploring opportunities for M&amp;A as well as to enhance and improve its product features. Additionally, the firm planned to expand its coverage of specialty care services aimed at individuals, employers, and union organizations.

Everside Health

Platforms offer a subscription-based or B2B-sponsored, evidence-based program for managing a specific long-term health condition.

DPCs offer value-based primary and preventive care services addressing whole-person (social, mental, physical) needs for a fixed monthly or annual fee paid by either the patient, insurance provider, or employer.

Companies offer B2B and D2C evidence-based treatments delivered via software programs to prevent and manage a variety of chronic conditions.

Tools that collect and analyze real-time patient data that supports healthcare providers with clinical decisions,  improves patient outcomes, and reduces medical errors.

Companies offer independent physician practices and hospitals with the tools (patient engagement, care coordination, administrative services) to help manage and improve clinical health outcomes of a defined group of individuals or large populations.

Platforms are used to track and gather patient health-related information via either a connected device or at-home test kits to detect the early onset of disease and identify any abnormalities in readings—but do not include a treatment plan.

To gather large amounts of real-time data for chronic care management, DTx, and patient monitoring

XR used by some startups for chronic pain management

Offers digital means of providing direct primary care, passive remote monitoring, chronic care management, etc.

AI/ML is used in predictive analytics, diagnostics tools, and population management

Offers tailored preventive interventions and treatments to the specific needs and characteristics of each individual

<div>
 
 Orpyx Medical Technologies, a company focusing on the prevention of diabetic foot ulcers, has received $20 million in growth funding from Perceptive Advisors. The additional funds will help speed up commercial efforts to provide solutions for patients and healthcare providers. The aim is to improve outcomes for those at risk of complications from diabetic foot ailments. 
 The Sensory Insole system developed by Orpyx enhances custom orthotics with multi-modal sensor technology. This allows for continuous remote monitoring of plantar pressure, temperature, and activity, as well as adherence to the program. Partnerships with health plans and organizations such as the Veterans Health Administration help in the prevention efforts for diabetic foot ulcers and related amputations. 
 Analyst QuickTake: Diabetic foot ulcer is a preventable health issue common to diabetes patients and can lead to amputations if not treated. In the US, about 130,000 diabetes-related amputations are carried out each year. Podimetrics, MR3Health, and Siren Care are other companies working on solutions for diabetic foot ulcer detection.
 
</div>

Orpyx Medical Technologies

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless